Important New Advice on the use of topical choline salicylates
in children under 16

23^rd April 2009

There is new advice from the Medicines and Healthcare products Regulatory Agency (MHRA) that topical products containing choline salicylate - the main active ingredient in bonjela and bonjela cool mint gel - should no longer be used by children under the age of 16.

This advice is purely precautionary because of a theoretical risk. There are no new safety concerns.

bonjela and bonjela cool mint gel continue to be suitable and effective treatments for mouth ulcers in adults and adolescents 16 years or over. Parents whose children have previously used the products can be assured that there is very little risk of adverse reaction.

bonjela teething gel is totally unaffected by this new advice and remains suitable for teething babies over 2 months.

New packaging for the bonjela range will clearly highlight which products are suitable for adults and which for children. Anyone with concerns should speak to their pharmacist or GP.

Please click here for bonjela statement on this subject. Or for further information on the MHRA's new advice, click here. If you have any further questions, please contact our Medical Information Unit on 0500 455 456.

Press enquiries: Please contact our PR Agency, the firm on 020 8899 6110